DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With HER2 IHC2+/3+ ESCC

Clinical trial NCT06055153 · UNKNOWN

Trial details

NCT number: NCT06055153
Sponsor: Changhai Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Carcinoma HER-2 Protein Overexpression

Start date: 2023-09-30
Primary completion: 2025-02-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.